Trial Profile
EXPAREL Dose-Response for Single-Injection Femoral Nerve Blocks: A Pharmacodynamics Investigation in Healthy Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Mar 2021
Price :
$35
*
At a glance
- Drugs Bupivacaine (Primary)
- Indications Postoperative pain
- Focus Pharmacodynamics
- 07 Aug 2012 Trial phase changed from I to I/II and official title amended as reported by ClinicalTrials.gov.
- 07 May 2012 Actual patient number 14 added as reported by ClinicalTrials.gov.
- 07 May 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.